Topically applied thiabendazole in the treatment of scabies.
Forty patients were treated for scabies with a 10% suspension of thiabendazole applied externally. Thirty-two patients (80%) had a satisfactory response to one course of therapy, while a second course was necessary in six (15%). Two patients (5%) required intralesional injections of triamcinolone diacetate because of persistent scabious nodules.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004485:Eczema / Q000150:complications; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D012532:Scabies / Q000150:complications / Q000188:drug therapy*; D012874:Skin Diseases, Infectious / Q000150:complications; D012996:Solutions; D013827:Thiabendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D014221:Triamcinolone / Q000627:therapeutic use
D012996:Solutions; D014221:Triamcinolone; D013827:Thiabendazole